mesothelioma - Articles and news items

Immunotherapy plus live bacterium shows promise in malignant pleural mesothelioma

Industry news / 14 April 2016 / Victoria White, Digital Content Producer

Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in malignant pleural mesothelioma…

Tremelimumab mesothelioma trial fails to meet primary endpoint

Industry news / 29 February 2016 / Victoria White

DETERMINE, the Phase IIb clinical trial of tremelimumab monotherapy in second or third-line treatment of unresectable malignant mesothelioma, did not meet its primary endpoint of overall survival…

Targovax submits study protocol for ONCOS-102 to Spanish authorities

Industry news / 2 February 2016 / Victoria White

Targovax has submitted a study protocol to the regulatory authorities in Spain to assess ONCOS-102 in patients with malignant pleural mesothelioma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+